The results revealed that whereas ATG7 inhibition did not suppress CRC cell proliferation, it effectively caused an immune response for targeted tumor clearance in vivo, thereby highlighting the key role of CD8+ T cells in regulating the observed anti-tumor immunity in ATG7-deficient CRC. The gene discussed is ATG7; the disease is neoplasm.